Howard Horn, CFO of Ultragenyx Pharmaceutical RARE, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $1.1M. The latest trade was on 06/01.

HH

HH

Howard Horn

CFO

Company

Ultragenyx Pharmaceutical RARE

First filing

23/02/21

Trades

23 trades

Buys / sales

0 / 14

12-month net buying

−$1.1M

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ultragenyx PharmaceuticalRARE	Open-market sale10b5-1 plan	06/01	06/01	4,653 sh	$23.77	$110,601.81	−4.2%
Ultragenyx PharmaceuticalRARE	Open-market sale10b5-1 plan	05/01	05/04	4,683 sh	$24.90	$116,606.7	−4.1%
Ultragenyx PharmaceuticalRARE	Open-market sale10b5-1 plan	04/01	04/02	4,683 sh	$20.97	$98,202.51	−5.5%
Ultragenyx PharmaceuticalRARE	Open-market sale10b5-1 plan	03/02–03/03	03/03	10,044 sh3 trades	$22.65avg.	$227,538.26	−10.6%
Ultragenyx PharmaceuticalRARE	Open-market sale10b5-1 plan	02/02	02/03	3,061 sh	$23.56	$72,117.16	−3.3%
Ultragenyx PharmaceuticalRARE	Open-market sale10b5-1 plan	01/02	01/05	3,150 sh	$22.84	$71,946	−3.3%
Ultragenyx PharmaceuticalRARE	Open-market sale10b5-1 plan	25/12/10	25/12/11	3,081 sh	$36.38	$112,086.78	−3.1%
Ultragenyx PharmaceuticalRARE	Open-market sale	25/10/13	25/10/14	7,942 sh	$31.51	$250,252.42	−7.5%
Ultragenyx PharmaceuticalRARE	Open-market sale	25/03/06	25/03/10	1,785 sh	$40.40	$72,114	−1.7%
Ultragenyx PharmaceuticalRARE	Open-market sale	24/10/10	24/10/11	7,465 sh	$52.76	$393,853.4	−7.5%
Vir BiotechnologyVIR	Open-market sale	23/02/23	23/02/24	2,248 sh	$25.97	$58,380.56	−1.0%
Vir BiotechnologyVIR	Open-market sale	23/02/17	23/02/21	2,424 sh	$25.29	$61,302.96	−1.0%